InvestorsObserver
×
News Home

Mirati Therapeutics Inc (MRTX) Stock: What Does the Chart Say Wednesday?

Wednesday, October 06, 2021 10:01 AM | InvestorsObserver Analysts

Mentioned in this article

Mirati Therapeutics Inc (MRTX) Stock: What Does the Chart Say Wednesday?

Mirati Therapeutics Inc (MRTX) stock is lower by 7.42% over the past week and gets a Bearish rating from InvestorsObserver Sentiment Indicator.

Sentiment Score - ,bearish
Mirati Therapeutics Inc has a Bearish sentiment reading. Find out what this means for you and get the rest of the rankings on MRTX!

What is Stock Sentiment?

Sentiment is a very short-term indicator that is entirely technical. There is no information about the health of profitability of the underlying company in our sentiment score. As a technical indicator, news about the stock, or company, such as an earnings release or other event, could move the stock counter to the recent trend. Price action is generally the best indicator of sentiment. For a stock to go up, investors must feel good about it. Similarly, a stock that is in a downtrend must be out of favor. InvestorsObserver’s Sentiment Indicator considers price action and recent trends in volume. Increasing volumes often mean that a trend is strengthening, while decreasing volumes can signal that a reversal could come soon. The options market is another place to get signals about sentiment. Since options allow investors to place bets on the price of a stock, we consider the ratio of calls and puts for stocks where options are available.

What's Happening With MRTX Stock Today?

Mirati Therapeutics Inc (MRTX) stock is higher by 2.01% while the S&P 500 is down -0.93% as of 9:58 AM on Wednesday, Oct 6. MRTX is up $3.18 from the previous closing price of $158.12 on volume of 102,227 shares. Over the past year the S&P 500 has risen 26.31% while MRTX is down -4.26%. MRTX lost -$9.94 per share in the over the last 12 months. To see InvestorsObserver's Sentiment Score for Mirati Therapeutics Inc click here.

More About Mirati Therapeutics Inc

Mirati Therapeutics is an American biotechnology company. The company's medical focus is precision medicine: genetically targeted oncology therapeutics for selected patients. Mirati's drug candidates target specific genetic and epigenetic drivers of cancer. Click Here to get the full Stock Report for Mirati Therapeutics Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App